We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Inventiva Sa | LSE:0RNK | London | Ordinary Share | FR0013233012 | INVENTIVA ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.62 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 7,499 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 23.16M | -110.43M | -2.1189 | -1.42 | 156.35M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 18/3/2024 | 20:00 | UKREG | Inventiva annonce les résultats positifs de l’essai clinique de Phase II,.. |
| 18/3/2024 | 20:00 | UKREG | Inventiva announces positive results from the Phase II, LEGEND,.. |
| 13/3/2024 | 20:00 | UKREG | Inventiva annonce la présentation des résultats de son étude clinique de.. |
| 13/3/2024 | 20:00 | UKREG | Inventiva to present the results of LEGEND Phase IIa combination trial with.. |
| 07/3/2024 | 21:00 | UKREG | Inventiva announces that screening in the NATiV3, Phase III, clinical trial.. |
| 07/3/2024 | 21:00 | UKREG | Inventiva annonce la reprise du screening dans l’étude clinique de Phase.. |
| 15/2/2024 | 21:35 | UKREG | Inventiva reports preliminary 2023 fiscal year financial Information¹ and.. |
| 15/2/2024 | 21:35 | UKREG | Inventiva publie ses informations financières préliminaires pour l’exercice.. |
1 Year Inventiva Chart |
Intraday Inventiva Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
